Article Versions Notes

Salama EE, Youssef MF, Aboelmagd A, Boraei ATA, Nafie MS, Haukka M, Barakat A, Sarhan AAM. Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals. 2023; 16(12):1724. https://doi.org/10.3390/ph16121724

Salama, Eid E., Mohamed F. Youssef, Ahmed Aboelmagd, Ahmed T. A. Boraei, Mohamed S. Nafie, Matti Haukka, Assem Barakat, and Ahmed A. M. Sarhan. 2023. "Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation" Pharmaceuticals 16, no. 12: 1724. https://doi.org/10.3390/ph16121724

Salama, E. E., Youssef, M. F., Aboelmagd, A., Boraei, A. T. A., Nafie, M. S., Haukka, M., Barakat, A., & Sarhan, A. A. M. (2023). Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals, 16(12), 1724. https://doi.org/10.3390/ph16121724